CMPX Compass Therapeutics, Inc. - Common Stock
$2.49
价格 · 八月 19, 2026
截至...的财报数据 八月 6, 2026
CMPX 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$2.48
市值
$443M
P/E (TTM)
—
每股收益 (TTM)
—
营收 (TTM)
$0
股息收益率
—
ROE
-45.9%
负债/权益
—
52周区间
$2 – $7
CMPX 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
Configure
10年表现 收入、净利润、利润率和每股收益趋势
营收与净利润
$0
2023-12-31
→
2025-12-31
EPS
—
自由现金流
$-49M
2020-12-31
→
2025-12-31
利润率
—
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
指标
5年趋势
CMPX
同行中位数
P/B (市净率)
2.3
4.8
Price / FCF (股价/自由现金流)
-9.0
—
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
指标
5年趋势
CMPX
同行中位数
ROA
-36.9%
-41.1%
ROE
-45.9%
-52.6%
财务健康 债务、流动性、偿付能力 — 资产负债表强度
指标
5年趋势
CMPX
同行中位数
Current Ratio (流动比率)
15.0
7.7
Quick Ratio (速动比率)
15.0
—
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
指标
5年趋势
CMPX
同行中位数
资本效率 资产周转率、库存周转率、应收账款周转率
指标
5年趋势
CMPX
同行中位数
CMPX 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
买入
21 位分析师
- 强烈买入 9 42.9%
- 买入 10 47.6%
- 持有 2 9.5%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
12 位分析师 · 2026-08-13
中位数
$7.00
平均值
$8.92
← 低于所有目标
$2.48
最低
$5.00
最高
$24.00
中位数目标
$7.00
+181.7%
平均目标
$8.92
+258.8%
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
0.00%
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $-0.13 | $-0.11 | -0.02% |
| 2026年3月31日 | $-0.10 | $-0.10 | 0.00% |
| 2025年12月31日 | $-0.09 | $-0.09 | 0.00% |
| 2025年9月30日 | $-0.08 | $-0.14 | 0.06% |
| 2025年6月30日 | $-0.14 | $-0.12 | -0.02% |
| 2025年3月31日 | $-0.12 | $-0.11 | -0.01% |
同行比较（GICS 子行业） 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| CMPX | $958M | — | — | — | -45.9% | — |
| PBYI | $300M | 9.8 | -0.91% | 13.6% | 26.5% | — |
| RZLT | $388M | -4.6 | — | — | -56.9% | — |
| BNTC | $307M | -11.1 | — | — | -43.8% | — |
| EDIT | $201M | -1.1 | 25.4% | -395.0% | -688.8% | — |
| PROK | — | — | 1075.0% | -7725.2% | 6.9% | — |
| FENC | $263M | -22.6 | -6.1% | -21.8% | -69.6% | — |
| LXEO | $725M | -5.3 | — | — | -51.9% | — |
| CAPR | $1.66B | -12.8 | -11.6% | — | -51.1% | — |
| FHTX | $306M | -4.6 | 36.8% | -240.3% | 80.2% | — |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | $0 | $850.0K | $0 | |
| R&D Expense | $56M | $42M | $38M | |
| SG&A Expense | $17M | $15M | $12M | |
| Operating Expenses | $73M | $57M | $50M | |
| Operating Income | $-73M | $-57M | $-50M | |
| Interest Income | $6M | $7M | $8M | |
| Other Non-op | $6M | $7M | $8M | |
| Pretax Income | · | · | $-42M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-66M | $-49M | $-42M | |
| EPS (Basic) | $-0.42 | $-0.36 | $-0.33 | |
| Shares (Basic) | 157,695,000 | 137,384,000 | 127,027,000 | |
| Shares (Diluted) | · | 137,400,000 | · | |
| EBITDA | $-73M | $-57M | $-50M |
资产负债表 20
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Cash & Equivalents | $31M | $43M | $24M | |
| Short-term Investments | $178M | $83M | $128M | |
| Prepaid Expense | $913.0K | $6M | $1M | |
| Current Assets | $210M | $133M | $154M | |
| PP&E (Net) | $102.0K | $353.0K | $898.0K | |
| PP&E (Gross) | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $6M | $6M | |
| Other Non-current Assets | · | $568.0K | $320.0K | |
| Total Assets | $220M | $140M | $157M | |
| Accounts Payable | $2M | $2M | $4M | |
| Accrued Liabilities | $11M | $6M | $3M | |
| Current Liabilities | $14M | $9M | $8M | |
| Capital Leases | $9M | $6M | $536.0K | |
| Total Liabilities | $23M | $15M | $8M | |
| Common Stock | $18.0K | $14.0K | $13.0K | |
| Retained Earnings | $-431M | $-365M | $-315M | |
| AOCI | $280.0K | $210.0K | $37.0K | |
| Stockholders' Equity | $197M | $125M | $149M | |
| Liabilities + Equity | $220M | $140M | $157M | |
| Shares Outstanding | 178,324,000 | 137,820,000 | 127,668,000 |
现金流 10
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| D&A | $276.0K | $589.0K | $699.0K | |
| Stock-based Comp | $8M | $9M | $6M | |
| Operating Cash Flow | $-49M | $-45M | $-41M | |
| CapEx | $25.0K | $44.0K | $30.0K | |
| Investing Cash Flow | $-93M | $47M | $27M | |
| Stock Issued | $138M | $18M | $3M | |
| Net Stock Activity | $138M | $18M | $3M | |
| Financing Cash Flow | $130M | $17M | $3M | |
| Net Change in Cash | $-13M | $19M | $-11M | |
| Free Cash Flow | $-49M | $-45M | $-41M |
盈利能力 6
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating Margin | · | -6661.8% | · | |
| Net Margin | · | -5808.8% | · | |
| EBITDA Margin | · | -6661.8% | · | |
| ROA | -36.9% | -33.2% | -23.8% | |
| ROE | -45.9% | -37.5% | -27.5% | |
| ROIC | · | · | -33.9% |
流动性与偿付能力 2
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Current Ratio | 15.0 | 15.0 | 19.7 | |
| Quick Ratio | 15.0 | 14.3 | 19.5 |
效率 1
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · |
估值 (TTM) 8
| 指标 | 趋势 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue TTM | $0 | $850.0K | $0 | |
| Net Income TTM | $-66M | $-49M | $-42M | |
| Market Cap | $958M | $200M | $199M | |
| P/S | · | 235.1 | · | |
| P/B | 4.9 | 1.6 | 1.3 | |
| P / Tangible Book | 4.9 | 1.6 | 1.3 | |
| P / Cash Flow | -19.5 | -4.5 | -4.9 | |
| P / FCF | -19.5 | -4.5 | -4.9 |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | · | $0 | $0 | $850.0K | · | $0 | $0 | $0 | |
| R&D Expense | · | $13M | $14M | $13M | $16M | $13M | $13M | $9M | $11M | $10M | · | · | · | |
| SG&A Expense | $7M | $7M | $4M | $3M | $5M | $5M | $4M | $4M | $5M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $27M | $20M | $18M | $16M | $21M | $18M | $17M | $12M | $16M | $13M | $15M | $12M | $13M | |
| Operating Income | $-27M | $-20M | $-18M | $-16M | $-21M | $-18M | $-17M | $-12M | $-15M | $-13M | $-15M | $-12M | $-13M | |
| Interest Income | · | · | · | · | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Other Non-op | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Pretax Income | · | · | · | · | · | $-17M | · | · | $-13M | $-11M | · | $-10M | $-11M | |
| Income Tax | · | · | · | · | · | $0 | · | · | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-25M | $-18M | $-16M | $-14M | $-20M | $-17M | $-15M | $-10M | $-13M | $-11M | $-13M | $-10M | $-11M | |
| EPS (Basic) | $-0.13 | $-0.10 | $-0.08 | $-0.08 | $-0.14 | $-0.12 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.10 | $-0.08 | $-0.09 | |
| Shares (Basic) | 186,798,000 | 186,400,000 | -287,605,000 | 168,782,000 | 138,282,000 | 138,236,000 | -274,402,000 | 137,589,000 | 137,589,000 | 136,608,000 | -253,501,000 | 127,424,000 | 126,729,000 | |
| Shares (Diluted) | · | · | · | · | · | 138,200,000 | 100,000 | 137,600,000 | · | · | · | · | · | |
| EBITDA | $-27M | $-20M | · | $-16M | $-21M | $-18M | · | $-12M | $-15M | $-13M | · | $-12M | $-13M |
资产负债表 20
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $35M | $55M | $31M | $46M | $23M | $41M | $43M | $37M | $19M | $24M | $24M | $30M | $19M | |
| Short-term Investments | $144M | $140M | $178M | $174M | $78M | $72M | $83M | $99M | $127M | $133M | $128M | $133M | $149M | |
| Prepaid Expense | $1M | $1M | $913.0K | $1M | $5M | $12M | $6M | $6M | $7M | $2M | $1M | $3M | $7M | |
| Current Assets | $181M | $196M | $210M | $221M | $106M | $124M | $133M | $141M | $154M | $159M | $154M | $167M | $175M | |
| PP&E (Net) | $324.0K | $169.0K | $102.0K | $119.0K | $131.0K | $231.0K | $353.0K | $493.0K | $592.0K | $744.0K | $898.0K | $1M | $1M | |
| PP&E (Gross) | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | $7M | |
| Accum. Depreciation | $7M | $7M | $7M | $7M | $7M | $7M | $6M | $7M | $7M | $6M | $6M | $6M | $6M | |
| Other Non-current Assets | · | · | · | · | · | · | · | $568.0K | $320.0K | $320.0K | $320.0K | $320.0K | $320.0K | |
| Total Assets | $190M | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Accounts Payable | $3M | $906.0K | $2M | $3M | $3M | $2M | $2M | $960.0K | $1M | $854.0K | $4M | $2M | $724.0K | |
| Accrued Liabilities | $12M | $8M | $11M | $9M | $11M | $13M | $6M | $3M | $7M | $2M | $3M | $6M | $8M | |
| Current Liabilities | $16M | $10M | $14M | $12M | $14M | $15M | $9M | $4M | $10M | $4M | $8M | $9M | $10M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $6M | $6M | $6M | $0 | $189.0K | $536.0K | $869.0K | $1M | |
| Total Liabilities | $24M | $19M | $23M | $22M | $23M | $21M | $15M | $11M | $10M | $4M | $8M | $10M | $11M | |
| Common Stock | $18.0K | $18.0K | $18.0K | $53.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | |
| Retained Earnings | $-475M | $-449M | $-431M | $-415M | $-401M | $-381M | $-365M | $-350M | $-339M | $-326M | $-315M | $-302M | $-292M | |
| AOCI | $-251.0K | $-159.0K | $280.0K | $274.0K | $208.0K | $190.0K | $210.0K | $486.0K | $-91.0K | $-90.0K | $37.0K | $-430.0K | $-507.0K | |
| Stockholders' Equity | $166M | $186M | $197M | $210M | $93M | $110M | $125M | $138M | $146M | $157M | $149M | $160M | $168M | |
| Liabilities + Equity | $190M | $205M | $220M | $231M | $117M | $131M | $140M | $149M | $156M | $161M | $157M | $170M | $179M | |
| Shares Outstanding | 180,088,000 | 180,088,000 | 178,324,000 | 177,572,000 | 138,282,000 | 138,282,000 | 137,820,000 | 137,589,000 | 137,589,000 | 137,589,000 | 127,668,000 | 127,445,000 | 127,388,000 |
现金流 10
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $21.0K | $15.0K | $17.0K | $19.0K | $100.0K | $140.0K | $140.0K | $143.0K | $152.0K | $154.0K | $161.0K | $164.0K | $180.0K | |
| Stock-based Comp | $5M | $5M | $2M | $1M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-15M | $-17M | $-13M | $-11M | $-12M | $-13M | $-9M | $-11M | $-11M | $-14M | $-12M | $-6M | $-10M | |
| CapEx | $176.0K | $82.0K | $0 | $7.0K | $0 | $18.0K | $0 | $44.0K | $0 | $0 | $9.0K | $10.0K | $11.0K | |
| Investing Cash Flow | $-5M | $38M | $-3M | $-95M | $-6M | $12M | $15M | $29M | $6M | $-4M | $6M | $17M | $-667.0K | |
| Stock Issued | · | · | $0 | $138M | $0 | $0 | $0 | $0 | $0 | $18M | $0 | $0 | $3M | |
| Net Stock Activity | · | · | · | · | · | $0 | · | · | · | $18M | · | · | · | |
| Financing Cash Flow | $0 | $3M | $1M | $129M | $0 | $-815.0K | $-94.0K | $-2.0K | $1.0K | $17M | $-158.0K | $21.0K | $3M | |
| Net Change in Cash | $-20M | $25M | $-16M | $23M | $-18M | $-2M | $6M | $18M | $-4M | $-554.0K | $-6M | $11M | $-8M | |
| Free Cash Flow | · | $-17M | · | · | · | $-13M | · | · | · | · | · | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| Net Margin | · | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | -1538.3% | · | · | · | · | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -1770.0% | · | · | · | · | |
| ROA | -16.4% | -10.9% | · | -7.5% | -14.6% | -11.4% | · | -6.6% | -7.8% | -6.2% | · | -6.7% | -7.1% | |
| ROE | -19.4% | -12.3% | · | -8.2% | -16.6% | -12.4% | · | -7.0% | -8.3% | -6.5% | · | -7.2% | -7.6% | |
| ROIC | · | · | · | · | · | -16.3% | · | · | -10.3% | -8.1% | · | -7.4% | -7.9% |
流动性与偿付能力 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 11.2 | 19.0 | · | 17.8 | 7.7 | 8.3 | · | 31.8 | 16.2 | 40.7 | · | 18.3 | 18.1 | |
| Quick Ratio | 11.2 | 18.9 | · | 17.7 | 7.3 | 7.6 | · | 30.5 | 15.4 | 40.1 | · | 17.9 | 17.4 |
效率 1
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | · | · | 0.0 | 0.0 | · | · | · | · |
估值 (TTM) 6
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-78M | $-69M | · | $-61M | $-60M | $-51M | · | $-44M | $-45M | $-40M | · | $-41M | $-40M | |
| Market Cap | $394M | $953M | · | $622M | $360M | $263M | · | $253M | $138M | $272M | · | $251M | $405M | |
| P/B | 2.4 | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Tangible Book | 2.4 | 5.1 | · | 3.0 | 3.9 | 2.4 | · | 1.8 | 0.9 | 1.7 | · | 1.6 | 2.4 | |
| P / Cash Flow | · | -55.2 | · | · | · | -19.9 | · | · | · | -19.6 | · | · | · | |
| P / FCF | · | -54.9 | · | · | · | -19.9 | · | · | · | · | · | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
损益表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 收入 | $0 | $850.0K | $0 | — | — |
| 营业利润率 % | — | -6661.8% | — | — | — |
| 净收入 | $-66M | $-49M | $-42M | $-39M | $-82M |
资产负债表
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | — | — | — | — | 0.0 |
| 流动比率 | 15.0 | 15.0 | 19.7 | 12.0 | 13.8 |
| 速动比率 | 15.0 | 14.3 | 19.5 | 11.5 | 13.6 |
现金流
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 自由现金流 | $-49M | $-45M | $-41M | $-34M | $-21M |
最新新闻 提及该公司的近期头条新闻
我的指标 您的个人关注列表 — 来自完整基本面的选定行
📊
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存，并会跟随您浏览所有股票。
机构持有人 (13F) 227 家申报者 · $346.6M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 72 (+23 与上一季度对比) | 42 (+22 与上一季度对比) | 76 (+11 与上一季度对比) | 45 (-2 与上一季度对比) | -5.0M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $39399813 | 17990782 | 11.37% | 股份 |
| VANGUARD GROUP INC | $37441444 | 6972336 | 10.80% | 股份 |
| ORBIMED ADVISORS LLC | $33331787 | 15219994 | 9.62% | 股份 |
| MONTANOVA CAPITAL, LLC | $30881538 | 14101159 | 8.91% | 股份 |
| STATE STREET CORP | $21798500 | 9953653 | 6.29% | 股份 |
| ENAVATE SCIENCES GP, LLC | $17056049 | 7788150 | 4.92% | 股份 |
| Vivo Capital, LLC | $16987961 | 7757060 | 4.90% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $13400133 | 6118782 | 3.87% | 股份 |
| Palo Alto Investors LP | $12771670 | 5831813 | 3.68% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $10322011 | 4713247 | 2.98% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8258560 | 3771032 | 2.38% | 股份 |
| Qube Research & Technologies Ltd | $8075601 | 3687489 | 2.33% | 股份 |
| Blue Owl Capital Holdings LP | $7936726 | 3624076 | 2.29% | 股份 |
| Rock Springs Capital Management LP | $7719595 | 3524929 | 2.23% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $7167845 | 3271990 | 2.07% | 股份 |
| GOLDMAN SACHS GROUP INC | $5881777 | 2685743 | 1.70% | 股份 |
| Birchview Capital, LP | $3668250 | 1675000 | 1.06% | 股份 |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $3066000 | 1400000 | 0.88% | 股份 |
| Fisher Asset Management, LLC | $3048238 | 1391890 | 0.88% | 股份 |
| ROYCE & ASSOCIATES LP | $2927548 | 1336780 | 0.84% | 股份 |
| FMR LLC | $2654709 | 1212196 | 0.77% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $2598435 | 1186500 | 0.75% | 股份 |
| Atle Fund Management AB | $2296418 | 1048593 | 0.66% | 股份 |
| Squarepoint Ops LLC | $2206440 | 1007507 | 0.64% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $2192054 | 1000938 | 0.63% | 股份 |
| Blackstone Inc. | $1970860 | 899936 | 0.57% | 股份 |
| FIRST TRUST ADVISORS LP | $1767338 | 807004 | 0.51% | 股份 |
| KVP Capital Advisors, LP | $1688490 | 771000 | 0.49% | 股份 |
| UBS Group AG | $1560951 | 712763 | 0.45% | 股份 |
| CITIGROUP INC | $1546887 | 706341 | 0.45% | 股份 |
| Burkehill Global Management, LP | $1533000 | 700000 | 0.44% | 股份 |
| JPMORGAN CHASE & CO | $1505377 | 696934 | 0.43% | 股份 |
| Point72 Asset Management, L.P. | $1503604 | 686577 | 0.43% | 股份 |
| ACUTA CAPITAL PARTNERS, LLC | $1303516 | 595213 | 0.38% | 股份 |
| CM Management, LLC | $1204500 | 550000 | 0.35% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $1147072 | 523777 | 0.33% | 股份 |
| MORGAN STANLEY | $1088441 | 497005 | 0.31% | 股份 |
| DIMENSIONAL FUND ADVISORS LP | $1045092 | 477211 | 0.30% | 股份 |
| BANK OF AMERICA CORP /DE/ | $994089 | 453922 | 0.29% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $856345 | 161880 | 0.25% | 股份 |
| Artia Global Partners LP | $839208 | 383200 | 0.24% | 股份 |
| ArrowMark Colorado Holdings LLC | $798785 | 364742 | 0.23% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $701483 | 320312 | 0.20% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $675166 | 308295 | 0.19% | 股份 |
| ALGERT GLOBAL LLC | $674761 | 308110 | 0.19% | 股份 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $663874 | 303139 | 0.19% | 股份 |
| NATIXIS | $651996 | 297715 | 0.19% | 股份 |
| Exome Asset Management LLC | $604801 | 276165 | 0.17% | 股份 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $594152 | 112316 | 0.17% | 股份 |
| Caption Management, LLC | $577234 | 263577 | 0.17% | 股份 |
| TEMA ETFS LLC | $537945 | 100176 | 0.16% | 股份 |
| Seven Fleet Capital Management LP | $510415 | 233066 | 0.15% | 股份 |
| DV EQUITIES, LLC | $510415 | 233066 | 0.15% | 股份 |
| PANAGORA ASSET MANAGEMENT INC | $486572 | 222179 | 0.14% | 股份 |
| XTX Topco Ltd | $476292 | 217485 | 0.14% | 股份 |
| Orion Porfolio Solutions, LLC | $468360 | 213863 | 0.14% | 股份 |
| Optimize Financial Inc | $425522 | 80439 | 0.12% | 股份 |
| Rafferty Asset Management, LLC | $416376 | 190126 | 0.12% | 股份 |
| ALPS ADVISORS INC | $400282 | 182777 | 0.12% | 股份 |
| Mariner, LLC | $378432 | 172821 | 0.11% | 股份 |
| Swiss National Bank | $376023 | 171700 | 0.11% | 股份 |
| JANE STREET GROUP, LLC | $372300 | 170000 | 0.11% | 买入期权 |
| Virtus Investment Advisers, LLC | $352986 | 161181 | 0.10% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $352371 | 160900 | 0.10% | 股份 |
| RHUMBLINE ADVISERS | $346984 | 158444 | 0.10% | 股份 |
| JANUS HENDERSON GROUP PLC | $293846 | 55600 | 0.08% | 股份 |
| IEQ CAPITAL, LLC | $269256 | 122948 | 0.08% | 股份 |
| ADAR1 Capital Management, LLC | $267469 | 122132 | 0.08% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $249165 | 113774 | 0.07% | 股份 |
| Bank of New York Mellon Corp | $242878 | 110903 | 0.07% | 股份 |
| WELLS FARGO & COMPANY/MN | $240447 | 109793 | 0.07% | 股份 |
| Quadrature Capital Ltd | $237068 | 108250 | 0.07% | 股份 |
| MERCER GLOBAL ADVISORS INC /ADV | $233388 | 106570 | 0.07% | 股份 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $230198 | 105113 | 0.07% | 股份 |
| PROFUND ADVISORS LLC | $208508 | 95209 | 0.06% | 股份 |
| Schonfeld Strategic Advisors LLC | $201975 | 92227 | 0.06% | 股份 |
| TUDOR INVESTMENT CORP ET AL | $197196 | 90044 | 0.06% | 股份 |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $194711 | 83567 | 0.06% | 股份 |
| Jain Global LLC | $193381 | 88302 | 0.06% | 股份 |
| SmartHarvest Portfolios, LLC | $189453 | 86508 | 0.05% | 股份 |
| GROUP ONE TRADING LLC | $178610 | 81557 | 0.05% | 股份 |
| BlackRock, Inc. | $178213 | 81376 | 0.05% | 股份 |
| CITADEL ADVISORS LLC | $177390 | 81000 | 0.05% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $163569 | 74689 | 0.05% | 股份 |
| CITADEL ADVISORS LLC | $161622 | 73800 | 0.05% | 买入期权 |
| MetLife Investment Management, LLC | $156412 | 71421 | 0.05% | 股份 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $149395 | 68217 | 0.04% | 股份 |
| ExodusPoint Capital Management, LP | $147777 | 67478 | 0.04% | 股份 |
| CITADEL ADVISORS LLC | $143445 | 65500 | 0.04% | 卖出期权 |
| D. E. Shaw & Co., Inc. | $141612 | 64663 | 0.04% | 股份 |
| Vanguard Global Advisers, LLC | $133936 | 61158 | 0.04% | 股份 |
| Wealthcare Advisory Partners LLC | $133507 | 60962 | 0.04% | 股份 |
| Quantbot Technologies LP | $133209 | 60826 | 0.04% | 股份 |
| JANE STREET GROUP, LLC | $131301 | 59955 | 0.04% | 股份 |
| SIMPLEX TRADING, LLC | $126560 | 57790 | 0.04% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $123078 | 56200 | 0.04% | 卖出期权 |
| Focus Partners Wealth | $116335 | 53121 | 0.03% | 股份 |
| Invesco Ltd. | $114701 | 52375 | 0.03% | 股份 |
| Sequoia Financial Advisors, LLC | $98507 | 44980 | 0.03% | 股份 |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $96172 | 43914 | 0.03% | 股份 |
公司内部人士 18 位内幕人士 · 8 位高管 · 12 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Thomas J. Schuetz | CHIEF EXECUTIVE OFFICER | 2026年2月8日 F | 6603336 | 0 | 0 | $0 |
| Vered Bisker-Leib | CHIEF EXECUTIVE OFFICER | 2024年2月8日 F | 3124426 | 0 | 0 | $0 |
| Barry Shin | CFO | 2026年1月2日 A | 525000 | 0 | 0 | $0 |
| Jonathan Anderman | General Counsel | 2026年4月29日 P | 196000 | 1 | 0 | $47250 |
| Neil Lerner | Chief Accounting Officer | 2026年4月29日 P | 397500 | 1 | 0 | $28350 |
| Arjun Prasad | Chief Commercial Officer | 2026年1月2日 A | — | 0 | 0 | $0 |
| Cynthia Sirard | Chief Medical Officer | 2026年1月2日 A | — | 0 | 0 | $0 |
| Susan Kalled | Chief Scientific Officer | 2022年2月18日 A | — | 0 | 0 | $0 |
| James P Boylan | 董事 | 2026年1月2日 A | — | 0 | 0 | $0 |
| Philip Ferneau | 董事 | 2026年1月2日 A | 400280 | 0 | 0 | $0 |
| Ellen Chiniara | 董事 | 2026年1月2日 A | — | 0 | 0 | $0 |
| GORDON CARL L | 董事 | 2026年1月2日 A | 0 | 0 | 0 | $0 |
| Mary Ann Gray | 董事 | 2026年1月2日 A | — | 0 | 0 | $0 |
| Richard S Lindahl | 董事 | 2026年1月2日 A | — | 0 | 0 | $0 |
| David M Wurzer | 董事 | 2023年2月8日 A | — | 0 | 0 | $0 |
| Brett Kaplan | 董事 | 2022年2月18日 A | — | 0 | 0 | $0 |
| Stephen P Squinto | 董事 | 2022年2月18日 A | — | 0 | 0 | $0 |
| Julie Sunderland | 董事 | 2020年6月19日 P | 2502025 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| Commander Aggregator, LP, Enavate Sciences, LP, Enavate Sciences GP, LLC, Enavate Sciences Holdings, LLC | 2025年8月18日 | 4.50% | 修订 | — | SEC |
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×7 申报 | 2025年8月15日 | 8.90% | 修订 | — | SEC |
| 未披露的报告人 | 2022年11月14日 | — | 初始申报 | 被动投资 | SEC |
| Philip Ferneau, Vox Health Fund, L.P., Borealis Capital Partners IV, LLC, Borealis Granite Fund, L.P., Borealis Capital Partners III, LLC | 2020年6月26日 | — | 初始申报 | — | SEC |
| Thomas J. Schuetz | 2020年6月26日 | — | 初始申报 | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 30 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| SBIO · ALPS ETF Trust | 0.27% | 185633 NS | 2026年5月31日 | N-PORT |
| BBC · ETFis Series Trust I | 0.25% | 53489 NS | 2026年4月30日 | N-PORT |
| FYC · First Trust Exchange-Traded Alpha... | 0.07% | 441490 NS | 2026年4月30日 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0.07% | 210822 NS | 2026年4月30日 | N-PORT |
| IWC · iShares Trust | 0.06% | 448663 SH | 2026年8月8日 | 每日 |
| FYX · First Trust Exchange-Traded Alpha... | 0.04% | 261767 NS | 2026年4月30日 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0.02% | 114090 SH | 2026年8月8日 | 每日 |
| IWN · iShares Trust | 0.02% | 1200652 SH | 2026年8月8日 | 每日 |
| FAD · First Trust Exchange-Traded Alpha... | 0.02% | 41165 NS | 2026年4月30日 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0.01% | 46574 NS | 2026年5月31日 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 754118 SH | 2026年8月8日 | 每日 |
| IWM · iShares Trust | 0.01% | 3388508 SH | 2026年8月8日 | 每日 |
| ITWO · ProShares Trust | 0.01% | 6071 NS | 2026年5月31日 | N-PORT |
| RSSL · Global X Funds | 0.01% | 55815 NS | 2026年4月30日 | N-PORT |
| UWM · ProShares Trust | 0.00% | 4749 NS | 2026年5月31日 | N-PORT |
| URTY · ProShares Trust | 0.00% | 4800 NS | 2026年5月31日 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0.00% | 51153 NS | 2026年4月30日 | N-PORT |
| WSML · iShares Trust | 0.00% | 6789 SH | 2026年8月8日 | 每日 |
| ONEQ · Fidelity Commonwealth Trust | 0.00% | 64580 NS | 2026年5月31日 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0.00% | 4596 NS | 2026年5月31日 | N-PORT |
| HDG · ProShares Trust | 0.00% | 121 NS | 2026年5月31日 | N-PORT |
| ITOT · iShares Trust | 0.00% | 244958 SH | 2026年8月8日 | 每日 |
| DFAS · Dimensional ETF Trust | 0.00% | 28557 NS | 2026年4月30日 | N-PORT |
| IWV · iShares Trust | 0.00% | 33872 SH | 2026年8月8日 | 每日 |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 1793659 SH | 2026年8月8日 | 每日 |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 4190754 SH | 2026年8月8日 | 每日 |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 11073 SH | 2026年8月8日 | 每日 |
| DFAU · Dimensional ETF Trust | 0.00% | 2437 NS | 2026年4月30日 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 7766 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0.00% | 257838 SH | 2026年8月8日 | 每日 |